lobbying_activities: 2876231

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2876231	14ae9924-11ba-4bb2-8f01-0f99d76d96fe	Q3	BUCHANAN INGERSOLL & ROONEY PC	55291	ALLAY THERAPEUTICS	2022	third_quarter	PHA	Develop and execute a government relations strategy relating to Allay Therapeutics agenda and new drug application (NDA).	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2022-10-19T12:48:30-04:00